Skip to Main Content

Advertisement

Skip Nav Destination

Issues

Journal Archive

Cancer Immunology Research (2013-Present)

(ISSN 2326-6066) Published monthly since 2013.

Cancer Immunity (2001-2013; volumes 1-13)

(EISSN 1424-9634) Published periodically from 2001-2013.

Table of Contents

Highlights from the Literature

Priority Briefs

Research Articles

Author Choice
Author Choice
Author Choice

Vaccine-activated CD8+ T cells that had weaker TCR signaling had stronger antitumor effects. Weak activation halted differentiation at the stem-like memory T-cell stage, generating more Tscm cells, and protected T effectors from antigen-induced exhaustion and apoptosis.

Close Modal

or Create an Account

Close Modal
Close Modal